Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients

Back

HFA Premium Access

Dapagliflozin's influence on cardiac remodeling in chronic heart failure patients

Session: Chronic heart failure - pathophysiology and mechanisms 7

Topic: Ventricular Remodelling

Speaker: Doctor A. Ribeiro Teixeira (Lisbon, PT)

Event: Heart Failure 2024

Congress Presentation

Add to my library

About the speaker

Doctor Ana Rita Ribeiro Teixeira

University Hospital Lisboa Central, Lisbon (Portugal)

0 follower

4 more presentations in this session

Prognostic implications of adaptive and maladaptive right ventricular hypertrophy in patients with heart failure: a prospective observational cohort study

Speaker: Doctor L. Dinc Asarcikli (Istanbul, TR)

Predictors of early left ventricular reverse remodelling and prognosis in new-onset heart failure of non-ischemic origin

Speaker: Doctor T. Hnat (Prague, CZ)

Cardiac reverse remodeling and SGLT2ii: insight from hemodynamic forces analysis

Speaker: Doctor S. Prosperi (Rome, IT)

Safety and tolerability of diuretics withdrawal in heart failure with reduced ejection fraction. The REDICAE trial

Speaker: Mr J. Torres Zamudio (Cordoba, ES)

Access the full session

Chronic heart failure - pathophysiology and mechanisms 7

Speakers: Doctor A. Ribeiro Teixeira, Doctor L. Dinc Asarcikli, Doctor T. Hnat, Doctor S. Prosperi, Mr J. Torres Zamudio

Access

About the event

Heart Failure 2024

11 May - 14 May 2024

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources